MOSCOW, February 14. /TASS/. COVID-19 is likely to develop resistance to drugs that are used for its treatment over time, the Russian Academy of Sciences’ associate member, Head of the Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases of the Sechenov University Alexander Lukashev stated on Sunday.
"Any effective treatment puts an evolutionary pressure on the virus. The virus is very good at adapting. When something hampers it, it changes and adapts. Therefore, the mass use of some antiviral drugs will make the virus change," the expert said, noting that this process is similar to the mechanism of building antibiotic resistance.
Answering a question whether the drugs used for the COVID-19 treatment could prevent the development of immunity against this infection, Lukashev stated that it was unlikely but was still possible. Meanwhile, in general, treatment cannot be effective without immunity and combating the virus only with drugs is extremely challenging. "When patients’ life is at stake, it makes little difference what kind of immunity they will have afterwards. This is not a reason to give up drugs," Lukashev concluded.